Aseptic Fill Finish Manufacturing Market by Type of Molecule, Type of Packaging Container Offered, Type of Drug Product, Scale of Operation, Company Size, Target Therapeutic Area and Geographical Regions : Industry Trends and Global Forecasts, Till 2035

As per Roots Analysis, the global aseptic fill finish manufacturing market is estimated to grow from USD 5.4 billion in the current year to USD 15 billion by 2035, at a CAGR of 9% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Molecules

Small Molecules
Biologics

Type of Packaging Containers Offered

Vials
Syringes
Ampoules
Cartridges

Type of Drug Products

Vaccine
Recombinant Proteins
Antibodies
Oligonucleotides
Gene Therapies
Cell Therapies
Other Products

Target Therapeutic Area

Autoimmune Disorders
Cardiovascular Disorders
Infectious Disorders
Oncological Disorders
Other Disorders

Scale of Operation

Preclinical / Clinical
Commercial

Company Size

Large
Mid-sized
Small

Key Geographical Regions

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America

ASEPTIC FILL FINISH MANUFACTURING MARKET: GROWTH AND TRENDS

Fill / finish is the final step in the downstream processing of a product, wherein the purified bulk formulation of the drug product is mixed with the necessary excipients and stabilizers and formulated and aliquoted into the appropriate dosage forms for clinical use or commercial distribution. These operations are usually carried out under aseptic conditions and are mostly automated. It is worth mentioning that aseptic fill finish manufacturing requires specialized automated equipment, clean room setup, skilled personnel, and continuous supervision to maintain the sterility and safety of the final drug product. Given the challenges associated with improper filling of drugs and to ensure the quality of end-products, innovators have developed a preference for outsourcing their aseptic fill / finish operations to contract service providers. Presently, contract fill-and-finish services are among the most outsourced services in the pharmaceutical domain. Driven by the growing trend of outsourcing, the opportunity within the aseptic fill / finish services market is anticipated to increase at a steady pace in the foreseen future.

ASEPTIC FILL FINISH MANUFACTURING MARKET: KEY INSIGHTS

The report delves into the current state of the aseptic fill finish manufacturing market and identifies potential growth opportunities within the industry. Some key findings from the report include:

Over 175 companies claim to offer fill / finish services for various types of biopharmaceutical drug products; the growth initiatives, in this segment, are being led by large and mid-sized players.
More than 70% of the service providers offer fill / finish for proteins and peptides; in addition, ~80% of the players have the required capabilities to carry out lyophilization operations.
Around 125 industry players offer fill / finish services for various types of small molecule drug products, across different scales of operation.

Aseptic Fill Finish Manufacturing Market - IMG1

Leveraging their expertise, 85% of stakeholders extend services for labelling and packaging, both for clinical and commercial scale operations.
In order to expand their aseptic fill / finish service portfolios and gain access to emerging technologies, companies are actively entering into strategic partnerships.
The aseptic fill / finish services market is likely to grow at a CAGR of ~11%, till 2035; this opportunity is expected to be well distributed across different types of molecules, packaging containers and drug products.
In the long-term, the US (~30%) is likely to significantly contribute towards the market growth, followed by Asia-Pacific countries; specifically, within Europe, Germany and France are likely to account for ~5% market share, each.

Aseptic Fill Finish Manufacturing Market - IMG2

ASEPTIC FILL FINISH MANUFACTURING MARKET: KEY SEGMENTS

Currently, Biologics Occupy the Largest Share of the Aseptic Fill Finish Manufacturing Market

Based on the type of molecule, the market is segmented into small molecules and biologics. At present, the biologic segment holds the maximum share of the aseptic fill finish manufacturing market. This trend is unlikely to change in the near future.

Syringes is the Fastest Growing Segment of the Aseptic Fill Finish Manufacturing Market

Based on the type of packaging container, the market is segmented into vials, syringes, ampoules, cartridges. Currently, vials hold the maximum share of the aseptic fill finish manufacturing market. It is worth highlighting that aseptic fill finish manufacturing market for syringes is likely to grow at a relatively higher CAGR.

Antibodies are Likely to Dominate the Aseptic Fill Finish Manufacturing Market During the Forecast Period

Based on the type of drug products, the market is segmented into vaccines, recombinant proteins, antibodies, oligonucleotides, gene therapies, cell therapies, other products. At present, antibodies hold the maximum share of the aseptic fill finish manufacturing market. This trend is likely to remain the same in the forthcoming years.

Oncological Disorders Account for the Largest Share of the Aseptic Fill Finish Manufacturing Market

Based on the therapeutic area, the market is segmented into autoimmune disorders, cardiovascular disorders, infectious disorders, oncological disorders, other disorders. While oncological disorders account for a relatively higher market share, it is worth highlighting that the autoimmune disorders segment is expected to witness substantial market growth in the coming years.

Based on the Scale of Operation, Commercial Scale is Likely to Dominate the Aseptic Fill Finish Manufacturing Market During the Forecast Period

Based on the scale of operation, the market is segmented into preclinical / clinical and commercial scale. Whilst commercial scale manufacturing will be the primary driver of the overall market, it is worth highlighting that the aseptic fill finish manufacturing market at preclinical / clinical scale is likely to grow at a relatively higher CAGR.

Large Companies Segment is the Fastest Growing Segment of the Aseptic Fill Finish Manufacturing Market During the Forecast Period

Based on the company size, the market is segmented into large, mid-sized and small companies. At present, large companies hold the maximum share of the aseptic fill finish manufacturing market. It is worth highlighting that the aseptic fill finish manufacturing market for small companies is likely to grow at a relatively higher CAGR.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Majority share is expected to be captured by players based in North America. It is worth highlighting that, over the years, the market in Asia-Pacific is expected to grow at a higher CAGR.

Example Players in the Aseptic Fill Finish Manufacturing Market

AbbVie Contract Manufacturing
Asymchem
Aenova
APL
BioPharma Solutions
BioReliance
Boehringer Ingelheim BioXcellence
Catalent Biologics
Charles River Laboratories
CordenPharma
Delpharm
Fareva
Fresenius Kabi
Glaxo SmithKline
Hetero Drugs
Intas Pharmaceuticals
Lonza
Pierre Fabre
Pfizer CentreOne
Plastikon Healthcare
Patheon
PiSA Farmaceutica
Recipharm
Wacker Biotech
Syngene
Sharp Services
Siegfried
Takara Bio
WuXi Biologics
Wockhardt

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

Former Chief Commercial Officer, IDT Biologika
Former Vice President of Business Development and Marketing, Cytovance Biologics
Vice President and Head of Formulation Development, Syngene
Head of Business Development, oncomed manufacturing
Former Technology Watch Manager, Yposkesi
International Business Developer, HALIX

ASEPTIC FILL FINISH MANUFACTURING MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the aseptic fill / finish manufacturing market, focusing on key market segments, including [A] type of molecule, [B] type of packaging container offered, [C] type of drug product, [D] scale of operation, [E] company size, [F] target therapeutic area and [G] key geographical regions.
Market Landscape 1: A comprehensive evaluation of sterile fill / finish service providers, considering various parameters, such as [A] year of establishment, [B] company size (in terms of number of employees), [C] location of headquarters, [D] type of molecule(s) and [E] type of packaging container(s) offered.
Market Landscape 2: A comprehensive evaluation of companies offering aseptic fill / finish services for biologics, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] location of fill / finish manufacturing facility, [E] type of packaging container(s) used, [F] type of biologic(s) manufactured, [G] scale of operation and [H] type of additional drug product-related service(s) offered.
Market Landscape 3: A comprehensive evaluation of companies offering aseptic fill / finish services for small molecules, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] location of fill finish manufacturing facility, [E] type of filling service(s) offered, [F] type of finishing service(s) offered, [G] type of packaging container(s) offered, [H] scale of operation, [I] types of dosage forms filled and [J] type of process(es).
Company Profiles: In-depth profiles of key aseptic fill / finish service providers based in North America, Europe and Asia Pacific, focusing on [A] company overviews, [B] service portfolio, [C] fill-finish manufacturing facility, [D] financial information (if available), [E] recent developments and [F] an informed future outlook.
Partnerships and Collaborations: An analysis of partnerships established in this sector based on multiple relevant parameters, such as [A] year of partnership, [B] type of partnership, [C] scale of operation, [D] type of molecule(s), [E] type of service(s) offered, [F] type of process(es) involved, [G] type of drug product(s) filled and [H] most active companies (in terms of number of partnerships) in the industry.
Case Study 1: A general discussion on the use of robotic systems in aseptic fill and finish operations. It provides a list of equipment used by fill / finish service providers, highlighting the purpose of robotics in various manufacturing operations. Additionally, it includes a list of companies offering robots for use in the manufacturing processes which are carried out in the pharmaceutical sector.
Case Study 2: A general discussion on the use of ready-to-use packaging components in aseptic fill / finish operations. It also includes information related to the advantages and disadvantages of ready-to-use packaging components, along with a list of suppliers providing these components.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What kind of partnership models are commonly adopted by industry stakeholders?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
10% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

Product Code: RA100422

1. PREFACE

1.1. Chapter Overview
1.2. Key Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to Contract Manufacturing
3.3. Commonly Outsourced Operations in Biopharmaceutical Industry
- 3.3.1. Aseptic Fill / Finish Operations
3.4. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.5. Advantages of Outsourcing Fill / Finish Operations
3.6. Risks and Challenges Associated with Outsourcing Fill / Finish Operations
3.7. Concluding Remarks

4. ASEPTIC FILL / FINISH SERVICE PROVIDERS LANDSCAPE

4.1. Chapter Overview
4.2. Aseptic Fill / Finish: Service Providers Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Type of Molecule(s)
- 4.2.5. Analysis by Type of Packaging Container(s) Offered

5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE

5.1. Chapter Overview
5.2. Biologics Fill / Finish: Service Providers Landscape
- 5.2.1. Analysis by Year of Establishment
- 5.2.2. Analysis by Company Size
- 5.2.3. Analysis by Location of Headquarters
- 5.2.4. Analysis by Location of Fill / Finish Facilities
- 5.2.5. Analysis by Type of Packaging Container(s) Offered
- 5.2.6. Analysis by Type of Drug Product(s) Involved
- 5.2.7. Analysis by Scale of Operation
- 5.2.8. Analysis by Additional Drug Product-related Services Offered
- 5.2.9. Information on Fill / Finish Capacity

6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE

6.1. Chapter Overview
6.2. Small Molecule Fill / Finish: Service Providers Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters
- 6.2.4. Analysis by Location of Fill / Finish Facilities
- 6.2.5. Analysis by Type of Filling Service(s) Offered
- 6.2.6. Analysis by Type of Finishing Service(s) Offered
- 6.2.7. Analysis by Type of Packaging Container(s) Offered
- 6.2.8. Analysis by Scale of Operation
- 6.2.9. Analysis by Type of Dosage Form(s) Filled
- 6.2.10. Analysis by Type of Process(es)
- 6.2.11. Information on Fill / Finish Capacity

7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA

7.1. Chapter Overview
7.2. Companies Offering Aseptic Fill / Finish Services for Biologics
- 7.2.1. AbbVie Contract Manufacturing
  - 7.2.1.1. Company Snapshot
  - 7.2.1.2. Financial Information
  - 7.2.1.3. Service Portfolio
  - 7.2.1.4. Fill / Finish Services Offered
  - 7.2.1.5. Recent Developments and Future Outlook
- 7.2.2. BioPharma Solutions
  - 7.2.2.1. Company Snapshot
  - 7.2.2.2. Financial Information
  - 7.2.2.3. Service Portfolio
  - 7.2.2.4. Fill / Finish Services Offered
  - 7.2.2.5. Recent Developments and Future Outlook
- 7.2.3. BioReliance
  - 7.2.3.1. Company Snapshot
  - 7.2.3.2. Financial Information
  - 7.2.3.3. Service Portfolio
  - 7.2.3.4. Fill / Finish Services Offered
  - 7.2.3.5. Recent Developments and Future Outlook
- 7.2.4. Catalent Biologics
  - 7.2.4.1. Company Snapshot
  - 7.2.4.2. Financial Information
  - 7.2.4.3. Service Portfolio
  - 7.2.4.4. Fill / Finish Services Offered
  - 7.2.4.5. Recent Developments and Future Outlook
- 7.2.5. Charles River Laboratories
  - 7.2.5.1. Company Snapshot
  - 7.2.5.2. Financial Information
  - 7.2.5.3. Fill / Finish Services Offered
  - 7.2.5.4. Recent Developments and Future Outlook
- 7.2.6. Patheon
  - 7.2.6.1. Company Snapshot
  - 7.2.6.2. Financial Information
  - 7.2.6.3. Service Portfolio
  - 7.2.6.4. Fill / Finish Services Offered
  - 7.2.6.5. Recent Developments and Future Outlook
7.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
- 7.3.2. Plastikon Healthcare
  - 7.3.2.1. Company Snapshot
  - 7.3.2.2. Service Portfolio
  - 7.3.2.3. Fill / Finish Services Offered
  - 7.3.2.4. Recent Developments and Future Outlook
- 7.3.3. Sharp Services
  - 7.3.3.1. Company Snapshot
  - 7.3.3.2. Service Portfolio
  - 7.3.3.3. Fill / Finish Services Offered
  - 7.3.3.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE

8.1. Company Overview
8.2. Companies Offering Aseptic Fill / Finish Services for Biologics
- 8.2.1. Boehringer Ingelheim BioXcellence
  - 8.2.1.1. Company Snapshot
  - 8.2.1.2. Financial Information
  - 8.2.1.3. Service Portfolio
  - 8.2.1.4. Fill / Finish Services Offered
  - 8.2.1.5. Recent Developments and Future Outlook
- 8.2.2. Fareva
  - 8.2.2.1. Company Snapshot
  - 8.2.2.2. Fill / Finish Services Offered
  - 8.2.2.3. Recent Developments and Future Outlook
- 8.2.3. GlaxoSmithKline
  - 8.2.3.1. Company Snapshot
  - 8.2.3.2. Financial Information
  - 8.2.3.3. Fill / Finish Services Offered
  - 8.2.3.4. Recent Developments and Future Outlook
- 8.2.4. Lonza
  - 8.2.4.1. Company Snapshot
  - 8.2.4.2. Financial Information
  - 8.2.4.3. Service Portfolio
  - 8.2.4.4. Fill / Finish Services Offered
  - 8.2.4.5. Recent Developments and Future Outlook
- 8.2.5. Pierre Fabre
  - 8.2.5.1. Company Snapshot
  - 8.2.5.2. Financial Information
  - 8.2.5.3. Service Portfolio
  - 8.2.5.4. Fill / Finish Services Offered
  - 8.2.5.5. Recent Developments and Future Outlook
- 8.2.6. Wacker Biotech
  - 8.2.6.1. Company Snapshot
  - 8.2.6.2. Financial Information
  - 8.2.6.3. Service Portfolio
- 8.2.6. 4. Fill / Finish Services Offered
  - 8.2.6.5. Recent Developments and Future Outlook
8.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
- 8.3.1. Aenova
  - 8.3.1.1. Company Snapshot
  - 8.3.1.2. Financial Information
  - 8.3.1.3. Service Portfolio
  - 8.3.1.4. Fill / Finish Services Offered
  - 8.3.1.5. Recent Developments and Future Outlook
- 8.3.2. APL
  - 8.3.2.1. Company Snapshot
  - 8.3.2.2. Service Portfolio
  - 8.3.2.3. Fill / Finish Services Offered
  - 8.3.2.4. Recent Developments and Future Outlook
- 8.3.3. CordenPharma
  - 8.3.3.1. Company Snapshot
  - 8.3.3.2. Service Portfolio
  - 8.3.3.3. Fill / Finish Services Offered
  - 8.3.3.4. Recent Developments and Future Outlook
- 8.3.4. Delpharm
  - 8.3.4.1. Company Snapshot
  - 8.3.4.2. Service Portfolio
  - 8.3.4.3. Fill / Finish Services Offered
  - 8.3.4.4. Recent Developments and Future Outlook
- 8.3.5. PiSA Farmaceutica
  - 8.3.5.1. Company Snapshot
  - 8.3.5.2. Service Portfolio
  - 8.3.5.3. Fill / Finish Services Offered
  - 8.3.5.4. Recent Developments and Future Outlook
8.4. Companies Offering Aseptic Fill / Finish Services for Biologics and Small Molecules
- 8.4.1. Fresenius Kabi
  - 8.4.1.1. Company Snapshot
  - 8.4.1.2 Financial Information
  - 8.4.1.3. Service Portfolio
  - 8.4.1.4. Fill / Finish Services Offered
  - 8.4.1.5. Recent Developments and Future Outlook
- 8.4.2. Recipharm
  - 8.4.2.1. Company Snapshot
  - 8.4.2.2. Financial Information
  - 8.4.2.3. Service Portfolio
  - 8.4.2.4. Fill / Finish Services Offered
  - 8.4.2.5. Recent Developments and Future Outlook

9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC

9.1. Company Overview
9.2. Companies Offering Aseptic Fill / Finish Services for Biologics
- 9.2.1. Asymchem
  - 9.2.1.1. Company Snapshot
  - 9.2.1.2. Financial Information
  - 9.2.1.3. Service Portfolio
  - 9.2.1.4. Fill / Finish Services Offered
  - 9.2.1.5. Recent Developments and Future Outlook
- 9.2.2. Samsung Biologics
  - 9.2.2.1. Company Snapshot
  - 9.2.2.2. Financial Information
  - 9.2.2.3. Service Portfolio
  - 9.2.2.4. Fill / Finish Services Offered
  - 9.2.2.5. Recent Developments and Future Outlook
- 9.2.3. Syngene
  - 9.2.3.1. Company Snapshot
  - 9.2.3.2. Financial Information
  - 9.2.3.3. Service Portfolio
  - 9.2.3.4. Fill / Finish Services Offered
  - 9.2.3.5. Recent Developments and Future Outlook
- 9.2.4. Takara Bio
  - 9.2.4.1. Company Snapshot
  - 9.2.4.2. Financial Information
  - 9.2.4.3. Service Portfolio
  - 9.2.4.4. Fill / Finish Services Offered
  - 9.2.4.5. Recent Developments and Future Outlook
- 9.2.5. WuXi Biologics
  - 9.2.5.1. Company Snapshot
  - 9.2.5.2. Financial Information
  - 9.2.5.3. Service Portfolio
  - 9.2.5.4. Fill / Finish Services Offered
  - 9.2.5.5. Recent Developments and Future Outlook
- 9.2.6. Hetero Drugs
  - 9.2.6.1. Company Snapshot
  - 9.2.6.2. Fill / Finish Services Offered
  - 9.2.6.3. Recent Developments and Future Outlook
- 9.2.7. Intas Pharmaceuticals
  - 9.2.7.1. Company Snapshot
  - 9.2.7.2. Fill / Finish Services Offered
  - 9.2.7.3. Recent Developments and Future Outlook
9.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
- 9.3.1. Siegfried
  - 9.3.1.1. Company Snapshot
  - 9.3.1.2. Financial Information
  - 9.3.1.3. Service Portfolio
  - 9.3.1.4. Fill / Finish Services Offered
  - 9.3.1.5. Recent Developments and Future Outlook
- 9.3.2. Wockhardt
  - 9.3.2.1. Company Snapshot
  - 9.3.2.2. Financial Information
  - 9.3.2.3. Service Portfolio
  - 9.3.2.4. Fill / Finish Services Offered
  - 9.3.2.5. Recent Developments and Future Outlook

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Aseptic Fill / Finish Service Providers: List of Partnerships and Collaborations
- 10.3.1. Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Analysis by Scale of Operation
- 10.3.4. Analysis by Type of Molecule(s) Involved
- 10.3.5. Analysis by Type of Service(s) Offered
- 10.3.6. Analysis by Type of Process(es) Involved
- 10.3.7. Analysis by Type of Drug Product(s) Involved
- 10.3.8. Most Active Players: Analysis by Number of Partnerships
- 10.3.9. Analysis by Geography
  - 10.3.9.1. Intercontinental and Intracontinental Agreements

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

11.1. Chapter Overview
11.2. Forecast Methodology
11.3. Overall Aseptic Fill / Finish Services Market, till 2035
- 11.3.1. Aseptic Fill / Finish Services Market: Analysis by Type of Molecule, till 2035
- 11.3.2. Aseptic Fill / Finish Services Market: Analysis by Type of Packaging Container Offered, till 2035
- 11.3.3. Aseptic Fill / Finish Services Market: Analysis by Type of Drug Product, till 2035
- 11.3.4. Aseptic Fill / Finish Services Market: Analysis by Target Therapeutic Area, till 2035
- 11.3.5. Aseptic Fill / Finish Services Market: Analysis by Scale of Operation, till 2035
- 11.3.6. Aseptic Fill / Finish Services Market: Analysis by Company Size, till 2035
- 11.3.7. Aseptic Fill / Finish Services Market: Analysis by Geography, till 2035
11.4. Aseptic Fill / Finish Services Market for Biologics, till 2035
- 11.4.1. Aseptic Fill / Finish Services Market for Biologics: Analysis by Type of Packaging Container Offered, till 2035
- 11.4.2. Aseptic Fill / Finish Services Market: Analysis by Type of Drug Product, till 2035
- 11.4.3. Aseptic Fill / Finish Services Market for Biologics: Analysis by Target Therapeutic Area, till 2035
- 11.4.4. Aseptic Fill / Finish Services Market for Biologics: Analysis by Scale of Operation, till 2035
- 11.4.5. Aseptic Fill / Finish Services Market for Biologics: Analysis by Company Size, till 2035
- 11.4.6. Aseptic Fill / Finish Services Market for Biologics: Analysis by Geography, till 2035
11.5. Aseptic Fill / Finish Services Market for Small Molecules, till 2035
- 11.5.1. Aseptic Fill / Finish Services Market for Small Molecules: Analysis by Type of Packaging Container Offered, till 2035
- 11.5.2. Aseptic Fill / Finish Services Market for Small Molecules: Analysis by Scale of Operation, till 2035
- 11.5.3. Aseptic Fill / Finish Services Market for Small Molecules: Analysis by Company Size, till 2035
- 11.5.4. Aseptic Fill / Finish Services Market for Small Molecules: Analysis by Geography, till 2035

12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING

12.1. Chapter Overview
12.2. Role of Robotic Systems in Pharmaceutical Industry
12.3. Role of Robotic Systems in Fill / Finish Operation
- 12.3.1. Types of Robots Used in Pharmaceutical Operations
- 12.3.2. Advantages Associated with Robotic Systems
- 12.3.3. Disadvantages Associated with Robotic Systems
- 12.3.4. Key Considerations for Selecting a Robotic System
12.4. Contract Service Providers: List of Fill / Finish Equipment
12.5. Companies Providing Robots for Use in the Pharmaceutical Industry
12.6. Companies Providing Isolator based Aseptic Filling Systems
12.7. Concluding Remarks

13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH

13.1. Chapter Overview
13.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
- 13.2.1. Advantages of Ready-to-Use Packaging Components
- 13.2.2. Disadvantages of Ready-to-Use Packaging Components
13.3. Companies Providing Ready-to-Use Packaging Components
13.4. Concluding Remarks

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS

15.1. Chapter Overview
15.2. IDT Biologika
- 15.2.1. Company Snapshot
- 15.2.1. Interview Transcript: Former Chief Commercial Officer
15.3. Cytovance Biologics
- 15.3.1. Company Snapshot
- 15.3.2. Interview Transcript: Former Vice President of Business Development and Marketing
15.4. Syngene
- 15.4.1. Company Snapshot
- 15.4.2. Interview Transcript: Vice President and Head of Formulation Development
15.5. oncomed manufacturing
- 15.5.1. Company Snapshot
- 15.5.2. Interview Transcript: Head of Business Development
15.6. Yposkesi
- 15.6.1. Company Snapshot
- 15.6.2. Interview Transcript: Former Technology Watch Manager
15.7. HALIX
- 15.7.1. Company Snapshot
- 15.7.2. Interview Transcript: International Business Developer

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Product Code: RA100422

List of Tables

Table 4.1 Aseptic Fill / Finish Service Providers: List of Companies
Table 4.2 Aseptic Fill / Finish Service Providers: Information on Type of Packaging Container(s) Offered
Table 5.1 Biologics Fill / Finish Service Providers: List of Companies
Table 5.2 Biologics Fill / Finish Service Providers: Information on Type of Packaging Container(s) Offered
Table 5.3 Biologics Fill / Finish Service Providers: Information on Type of Drug Product(s) Involved
Table 5.4 Biologics Fill / Finish Service Providers: Information on Scale of Operation
Table 5.5 Biologics Fill / Finish Service Providers: Information on Additional Drug Product-related Services Offered
Table 5.6 Biologics Fill / Finish Service Providers: Information on Fill / Finish Capacity
Table 6.1 Small Molecules Fill / Finish Service Providers: List of Companies
Table 6.2 Small Molecules Fill / Finish Service Providers: Information on Fill / Finish Technique
Table 6.3 Small Molecules Fill / Finish Service Providers: Information on Type of Packaging Container(s) Offered
Table 6.4 Small Molecules Fill / Finish Service Providers: Information on Scale of Operation
Table 6.5 Small Molecules Fill / Finish Service Providers: Information on Type of Dosage Form(s) Filled and Type of Process(es)
Table 6.6 Small Molecules Fill / Finish Service Providers: Information on Fill / Finish Capacity
Table 7.1 Biologics Fill / Finish Service Providers: List of Companies Profiled
Table 7.2 AbbVie Contract Manufacturing: Company Snapshot
Table 7.3 AbbVie Contract Manufacturing: Service Portfolio
Table 7.4 AbbVie Contract Manufacturing: Fill / Finish Services
Table 7.5 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 7.6 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 7.7 BioPharma Solutions: Company Snapshot
Table 7.8 BioPharma Solutions: Service Portfolio
Table 7.9 BioPharma Solutions: Fill / Finish Services
Table 7.10 BioPharma Solutions: Sterile Manufacturing Facilities
Table 7.11 BioPharma Solutions: Recent Developments and Future Outlook
Table 7.12 BioReliance: Company Snapshot
Table 7.13 BioReliance: Service Portfolio
Table 7.14 BioReliance: Fill / Finish Services
Table 7.15 BioReliance: Sterile Manufacturing Facilities
Table 7.16 BioReliance: Recent Developments and Future Outlook
Table 7.17 Catalent Biologics: Company Snapshot
Table 7.18 Catalent Biologics: Service Portfolio
Table 7.19 Catalent Biologics: Fill / Finish Services
Table 7.20 Catalent Biologics: Sterile Manufacturing Facilities
Table 7.21 Catalent Biologics: Recent Developments and Future Outlook
Table 7.22 Charles River Laboratories: Company Snapshot
Table 7.23 Charles River Laboratories: Fill / Finish Services
Table 7.24 Charles River Laboratories: Sterile Manufacturing Facilities
Table 7.25 Charles River Laboratories: Recent Developments and Future Outlook
Table 7.26 Patheon: Company Snapshot
Table 7.27 Patheon: Service Portfolio
Table 7.28 Patheon: Fill / Finish Services
Table 7.29 Patheon: Recent Developments and Future Outlook
Table 7.30 Small Molecules Fill / Finish Service Providers: List of Companies Profiled
Table 7.31 Pfizer CentreOne: Company Snapshot
Table 7.32 Pfizer CentreOne: Service Portfolio
Table 7.33 Pfizer CentreOne: Fill / Finish Services
Table 7.34 Pfizer CentreOne: Recent Developments and Future Outlook
Table 7.35 Plastikon Healthcare: Company Snapshot
Table 7.36 Plastikon Healthcare: Service Portfolio
Table 7.37 Plastikon Healthcare: Fill / Finish Services
Table 7.38 Sharp Services: Company Snapshot
Table 7.39 Sharp Services: Service Portfolio
Table 7.40 Sharp Services: Fill / Finish Services
Table 7.41 Sharp Services: Recent Developments and Future Outlook
Table 8.1 Biologics Fill / Finish Service Providers in Europe: List of Companies Profiled
Table 8.2 Boehringer Ingelheim BioXcellence: Company Snapshot
Table 8.3 Boehringer Ingelheim BioXcellence: Service Portfolio
Table 8.4 Boehringer Ingelheim BioXcellence: Fill / Finish Services
Table 8.5 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 8.6 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 8.7 Fareva: Company Snapshot
Table 8.8 Fareva: Fill / Finish Services
Table 8.9 Fareva: Recent Developments and Future Outlook
Table 8.10 Glaxo SmithKline: Company Snapshot
Table 8.11 Glaxo SmithKline: Fill / Finish Services
Table 8.12 Glaxo SmithKline: Recent Developments and Future Outlook
Table 8.13 Lonza: Company Snapshot
Table 8.14 Lonza: Service Portfolio
Table 8.15 Lonza: Fill / Finish Services
Table 8.16 Lonza: Recent Developments and Future Outlook
Table 8.17 Pierre Fabre: Company Snapshot
Table 8.18 Pierre Fabre: Service Portfolio
Table 8.19 Pierre Fabre: Fill / Finish Services
Table 8.20 Pierre Fabre: Sterile Manufacturing Facilities
Table 8.21 Pierre Fabre: Recent Developments and Future Outlook
Table 8.22 Wacker Biotech: Company Snapshot
Table 8.23 Wacker Biotech: Service Portfolio
Table 8.24 Wacker Biotech: Fill / Finish Services
Table 8.25 Wacker Biotech: Sterile Manufacturing Facilities
Table 8.26 Wacker Biotech: Recent Developments and Future Outlook
Table 8.27 Small Molecules Fill / Finish Service Providers in Europe: List of Companies Profiled
Table 8.28 Aenova: Company Snapshot
Table 8.29 Aenova: Service Portfolio
Table 8.30 Aenova: Fill / Finish Services
Table 8.31 Aenova: Recent Developments and Future Outlook
Table 8.32 APL: Company Snapshot
Table 8.33 APL: Service Portfolio
Table 8.34 APL: Fill / Finish Services
Table 8.35 CordenPharma: Company Snapshot
Table 8.36 CordenPharma: Service Portfolio
Table 8.37 CordenPharma: Fill / Finish Services
Table 8.38 CordenPharma: Recent Developments and Future Outlook
Table 8.39 Delpharm: Company Snapshot
Table 8.40 Delpharm: Service Portfolio
Table 8.41 Delpharm: Fill / Finish Services
Table 8.42 Delpharm: Recent Developments and Future Outlook
Table 8.43 PiSA Farmaceutica: Company Snapshot
Table 8.44 PiSA Farmaceutica: Fill / Finish Services
Table 8.45 Biologics and Small Molecules Fill / Finish Service Providers in Europe: List of Companies Profiled
Table 8.46 Fresenius Kabi: Company Snapshot
Table 8.47 Fresenius Kabi: Fill / Finish Services
Table 8.48 Recipharm: Company Snapshot
Table 8.49 Recipharm: Service Portfolio
Table 8.50 Recipharm: Fill / Finish Services
Table 8.51 Recipharm: Recent Developments and Future Outlook
Table 9.1 Biologics Fill / Finish Service Providers in Asia-Pacific: List of Companies Profiled
Table 9.2 Asymchem: Company Snapshot
Table 9.3 Asymchem: Service Portfolio
Table 9.4 Asymchem: Fill / Finish Services
Table 9.5 Asymchem: Sterile Manufacturing Facilities
Table 9.6 Asymchem: Recent Developments and Future Outlook
Table 9.7 Samsung Biologics: Company Snapshot
Table 9.8 Samsung Biologics: Service Portfolio
Table 9.9 Samsung Biologics: Fill / Finish Services
Table 9.10 Samsung Biologics: Recent Developments and Future Outlook
Table 9.11 Syngene: Company Snapshot
Table 9.12 Syngene: Service Portfolio
Table 9.13 Syngene: Fill / Finish Services
Table 9.14 Syngene: Recent Developments and Future Outlook
Table 9.15 Takara Bio: Company Snapshot
Table 9.16 Takara Bio: Service Portfolio
Table 9.17 Takara Bio: Fill / Finish Services
Table 9.18 Takara Bio: Recent Developments and Future Outlook
Table 9.19 WuXi Biologics: Company Snapshot
Table 9.20 WuXi Biologics: Services Portfolio
Table 9.21 Wuxi Biologics: Fill / Finish Services
Table 9.22 WuXi Biologics: Sterile Manufacturing Facilities
Table 9.23 WuXi Biologics: Recent Developments and Future Outlook
Table 9.24 Hetero Drugs: Company Snapshot
Table 9.25 Hetero Drugs: Fill / Finish Services
Table 9.26 Intas Pharmaceuticals: Company Snapshot
Table 9.27 Intas Pharmaceuticals: Fill / Finish Services
Table 9.28 Small Molecules Fill / Finish Service Providers in Asia-Pacific: List of Companies Profiled
Table 9.29 Siegfried: Company Snapshot
Table 9.30 Siegfried: Service Portfolio
Table 9.31 Siegfried: Fill / Finish Services
Table 9.32 Siegfried: Recent Developments and Future Outlook
Table 9.33 Wockhardt: Company Snapshot
Table 9.34 Wockhardt: Fill / Finish Services
Table 9.35 Wockhardt: Recent Developments and Future Outlook
Table 10.1 Aseptic Fill / Finish Service Providers: Partnerships and Collaborations
Table 10.2 Partnerships and Collaborations: Information on Type of Molecule(s) Involved and Type of Service(s) Offered
Table 10.3 Partnerships and Collaborations: Information on Type of Drug Product(s) Involved and Type of Process(es) Involved
Table 12.1 Contract Service Providers: Information on Fill / Finish Equipment
Table 12.2 List of Pharmaceutical Robotics Manufacturers
Table 12.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 13.1 List of Companies Supplying Ready-to-Use Aseptic Packaging Components
Table 16.1 Aseptic Fill / Finish Service Providers: Distribution by Year of Establishment
Table 16.2 Aseptic Fill / Finish Service Providers: Distribution by Company Size
Table 16.3 Aseptic Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 16.4 Aseptic Fill / Finish Service Providers: Distribution by Type of Molecule(s)
Table 16.5 Aseptic Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Table 16.6 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Table 16.7 Biologics Fill / Finish Service Providers: Distribution by Company Size
Table 16.8 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 16.9 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 16.10 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Table 16.11 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered and Type of Drug Product(s) Involved
Table 16.12 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Table 16.13 Biologics Fill / Finish Service Providers: Distribution by Additional Drug Product-related Services Offered
Table 16.14 Small Molecules Fill / Finish Service Providers: Distribution by Year of Establishment
Table 16.15 Small Molecules Fill / Finish Service Providers: Distribution by Company Size
Table 16.16 Small Molecules Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 16.17 Small Molecules Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 16.18 Small Molecules Fill / Finish Service Providers: Distribution by Type of Filling Service(s) Offered
Table 16.19 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finishing Service(s) Offered
Table 16.19 Small Molecules Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Table 16.20 Small Molecules Fill / Finish Service Providers: Distribution by Scale of Operation
Table 16.21 Small Molecules Fill / Finish Service Providers: Distribution by Type of Dosage Form(s) Filled
Table 16.22 Small Molecules Fill / Finish Service Providers: Distribution by Type of Process(es)
Table 16.23 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 16.24 Baxter (a parent company of BioPharma Solutions): Annual Revenues, FY 2017 Onwards (USD Billion)
Table 16.25 Merck (a parent company of BioReliance): Annual Revenues, FY 2017 Onwards (EUR Billion)
Table 16.26 Catalent Biologics: Annual Revenues, FY 2017 Onwards (USD Billion)
Table 16.27 Charles River Laboratories: Annual Revenues, FY 2017 Onwards (USD Billion)
Table 16.28 Thermo Fisher Scientific (a parent company of Patheon): Annual Revenues, FY 2017 Onwards (USD Billion)
Table 16.29 Pfizer CentreOne: Annual Revenues, FY 2017 Onwards (USD Million)
Table 16.30 Boehringer Ingelheim (a parent company of Boehringer Ingelheim BioXcellence): Annual Revenues, FY 2017 Onwards (EUR Billion)
Table 16.31 GlaxoSmithKline: Annual Revenues, FY 2017 Onwards (GBP Billion)
Table 16.32 Lonza: Annual Revenues, FY 2017 Onwards (CHF Billion)
Table 16.33 Pierre Fabre: Annual Revenues, FY 2018 Onwards (EUR Billion)
Table 16.34 Wacker Chemie (a parent company of Wacker Biotech): Annual Revenues, FY 2017 Onwards (EUR Billion)
Table 16.35 Aenova: Annual Revenues, FY 2018 Onwards (EUR Million)
Table 16.36 Fresenius Kabi: Annual Revenues, FY 2017 Onwards (EUR Billion)
Table 16.37 Recipharm: Annual Revenues, FY 2017 Onwards (SEK Billion)
Table 16.38 Recipharm: Revenues by Business Divisions, 2020 (SEK Billion)
Table 16.39 Asymchem: Annual Revenues, FY 2017 Onwards (USD Billion)
Table 16.40 Samsung Biologics: Annual Revenues, FY 2017 Onwards (KRW Billion)
Table 16.41 Syngene: Annual Revenues, FY 2017 Onwards (INR Million)
Table 16.42 Takara Bio: Annual Revenues, FY 2017 Onwards (JPY Billion)
Table 16.43 WuXi Biologics: Annual Revenues, FY 2017 Onwards (RMB Million)
Table 16.44 Siegfried: Annual Revenues, FY 2017 Onwards (CHF Million)
Table 16.45 Wockhardt: Annual Revenues, FY 2017 Onwards (INR Billion)
Table 16.46 Partnerships and Collaborations: Cumulative Year wise Trend, since 2013
Table 16.47 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.48 Partnerships and Collaborations: Distribution by Scale of Operation
Table 16.49 Partnerships and Collaborations: Distribution by Type of Molecule(s) Involved
Table 16.50 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Table 16.51 Partnerships and Collaborations: Distribution by Type of Process(es) Involved
Table 16.52 Partnerships and Collaborations: Distribution by Type of Drug Product(s) Involved
Table 16.53 Most Active Players: Distribution by Number of Partnerships
Table 16.54 Partnerships and Collaborations: Distribution by Geography
Table 16.55 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.56 Global Aseptic Fill / Finish Services Market, till 2035 (USD Billion)
Table 16.57 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Type of Molecule, till 2035 (USD Billion)
Table 16.58 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Table 16.59 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Type of Drug Product, till 2035 (USD Billion)
Table 16.60 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Target Therapeutic Area, till 2035 (USD Billion)
Table 16.61 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Scale of Operation, till 2035 (USD Billion)
Table 16.62 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Company Size, till 2035 (USD Billion)
Table 16.63 Aseptic Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios: Distribution by Geography, till 2035 (USD Billion)
Table 16.64 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios, till 2035 (USD Billion)
Table 16.65 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Table 16.66 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Type of Drug Product, till 2035 (USD Billion)
Table 16.67 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Target Therapeutic Area, till 2035 (USD Billion)
Table 16.68 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Scale of Operation, till 2035 (USD Billion)
Table 16.69 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Company Size, till 2035 (USD Billion)
Table 16.70 Aseptic Fill / Finish Services Market for Biologics, Conservative, Base and Optimistic Scenarios: Distribution by Geography, till 2035 (USD Billion)
Table 16.71 Aseptic Fill / Finish Services Market for Small Molecules, Conservative, Base and Optimistic Scenarios, till 2035 (USD Billion)
Table 16.72 Aseptic Fill / Finish Services Market for Small Molecules, Conservative, Base and Optimistic Scenarios: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Table 16.73 Aseptic Fill / Finish Services Market for Small Molecules, Conservative, Base and Optimistic Scenarios: Distribution by Scale of Operation, till 2035 (USD Billion)
Table 16.74 Aseptic Fill / Finish Services Market for Small Molecules, Conservative, Base and Optimistic Scenarios: Distribution by Company Size, till 2035 (USD Billion)
Table 16.75 Aseptic Fill / Finish Services Market for Small Molecules, Conservative, Base and Optimistic Scenarios: Distribution by Geography, till 2035 (USD Billion)

List of Figures

Figure 2.1 Executive Summary: Market Landscape of Biologics Fill / Finish Service Providers
Figure 2.2 Executive Summary: Market Landscape of Small Molecules Fill / Finish Service Providers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Types of Third-Party Service Providers
Figure 3.2 Commonly Outsourced Fill / Finish Operations
Figure 3.3 Steps Involved in Aseptic Fill / Finish Process
Figure 3.4 Blow-Fill-Seal Process
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges Associated with Outsourcing Aseptic Fill / Finish Operations
Figure 4.1 Aseptic Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Aseptic Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Aseptic Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Aseptic Fill / Finish Service Providers: Distribution by Type of Molecule(s)
Figure 4.5 Aseptic Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Figure 5.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 5.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Figure 5.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 5.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 5.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Figure 5.6 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered and Type of Drug Product(s) Involved
Figure 5.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 5.8 Biologics Fill / Finish Service Providers: Distribution by Additional Drug Product-related Services Offered
Figure 6.1 Small Molecules Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 6.2 Small Molecules Fill / Finish Service Providers: Distribution by Company Size
Figure 6.3 Small Molecules Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 6.4 Small Molecules Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 6.5 Small Molecules Fill / Finish Service Providers: Distribution by Type of Filling Service(s) Offered
Figure 6.6 Small Molecules Fill / Finish Service Providers: Distribution by Type of Finishing Service(s) Offered
Figure 6.7 Small Molecules Fill / Finish Service Providers: Distribution by Type of Packaging Container(s) Offered
Figure 6.8 Small Molecules Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 6.9 Small Molecules Fill / Finish Service Providers: Distribution by Type of Dosage Form(s) Filled
Figure 6.10 Small Molecules Fill / Finish Service Providers: Distribution by Type of Process(es)
Figure 7.1 AbbVie: Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 7.2 Baxter (a parent company of BioPharma Solutions): Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 7.3 Merck (a parent company of BioReliance): Annual Revenues, FY 2017 Onwards (EUR Billion)
Figure 7.4 Catalent Biologics: Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 7.5 Charles River Laboratories: Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 7.6 Thermo Fisher Scientific (a parent company of Patheon): Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 7.7 Pfizer CentreOne: Annual Revenues, FY 2017 Onwards (USD Million)
Figure 8.1 Boehringer Ingelheim (a parent company of Boehringer Ingelheim BioXcellence): Annual Revenues, FY 2017 Onwards (EUR Billion)
Figure 8.2 GlaxoSmithKline: Annual Revenues, FY 2017 Onwards (GBP Billion)
Figure 8.3 Lonza: Annual Revenues, FY 2017 Onwards (CHF Billion)
Figure 8.4 Pierre Fabre: Annual Revenues, FY 2018 Onwards (EUR Billion)
Figure 8.5 Wacker Chemie (a parent company of Wacker Biotech): Annual Revenues, FY 2017 Onwards (EUR Billion)
Figure 8.6 Aenova: Annual Revenues, FY 2018 Onwards (EUR Million)
Figure 8.7 Fresenius Kabi: Annual Revenues, FY 2017 Onwards (EUR Billion)
Figure 8.8 Recipharm: Annual Revenues, FY 2017 Onwards (SEK Billion)
Figure 8.9 Recipharm: Revenues by Business Divisions, 2020 (SEK Billion)
Figure 9.1 Asymchem: Annual Revenues, FY 2017 Onwards (USD Billion)
Figure 9.2 Samsung Biologics: Annual Revenues, FY 2017 Onwards (KRW Billion)
Figure 9.3 Syngene: Annual Revenues, FY 2017 Onwards (INR Million)
Figure 9.4 Takara Bio: Annual Revenues, FY 2017 Onwards (JPY Billion)
Figure 9.5 WuXi Biologics: Annual Revenues, FY 2017 Onwards (RMB Million)
Figure 9.6 Siegfried: Annual Revenues, FY 2017 Onwards (CHF Million)
Figure 9.7 Wockhardt: Annual Revenues, FY 2017 Onwards (INR Billion)
Figure 10.1 Partnerships and Collaborations: Cumulative Year wise Trend, since 2013
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Molecule(s) Involved
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Figure 10.6 Partnerships and Collaborations: Distribution by Type of Process(es) Involved
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Drug Product(s) Involved
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Distribution by Geography
Figure 10.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.1 Global Aseptic Fill / Finish Services Market, till 2035 (USD Billion)
Figure 11.2 Aseptic Fill / Finish Services Market: Distribution by Type of Molecule, till 2035 (USD Billion)
Figure 11.3 Aseptic Fill / Finish Services Market: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Figure 11.4 Aseptic Fill / Finish Services Market: Distribution by Type of Drug Product, till 2035 (USD Billion)
Figure 11.5 Aseptic Fill / Finish Services Market: Distribution by Target Therapeutic Area, till 2035 (USD Billion)
Figure 11.6 Aseptic Fill / Finish Services Market: Distribution by Scale of Operation, till 2035 (USD Billion)
Figure 11.7 Aseptic Fill / Finish Services Market: Distribution by Company Size, till 2035 (USD Billion)
Figure 11.8 Aseptic Fill / Finish Services Market: Distribution by Geography, till 2035 (USD Billion)
Figure 11.9 Aseptic Fill / Finish Services Market for Biologics, till 2035 (USD Billion)
Figure 11.10 Aseptic Fill / Finish Services Market for Biologics: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Figure 11.11 Aseptic Fill / Finish Services Market for Biologics: Distribution by Type of Drug Product, till 2035 (USD Billion)
Figure 11.12 Aseptic Fill / Finish Services Market for Biologics: Distribution by Target Therapeutic Area, till 2035 (USD Billion)
Figure 11.13 Aseptic Fill / Finish Services Market for Biologics: Distribution by Scale of Operation, till 2035 (USD Billion)
Figure 11.14 Aseptic Fill / Finish Services Market for Biologics: Distribution by Company Size, till 2035 (USD Billion)
Figure 11.15 Aseptic Fill / Finish Services Market for Biologics: Distribution by Geography, till 2035 (USD Billion)
Figure 11.16 Aseptic Fill / Finish Services Market for Small Molecules, till 2035 (USD Billion)
Figure 11.17 Aseptic Fill / Finish Services Market for Small Molecules: Distribution by Type of Packaging Container Offered, till 2035 (USD Billion)
Figure 11.18 Aseptic Fill / Finish Services Market for Small Molecules: Distribution by Scale of Operation, till 2035 (USD Billion)
Figure 11.19 Aseptic Fill / Finish Services Market for Small Molecules: Distribution by Company Size, till 2035 (USD Billion)
Figure 11.20 Aseptic Fill / Finish Services Market for Small Molecules: Distribution by Geography, till 2035 (USD Billion)
Figure 12.1 Key Considerations for Selecting a Robotic System
Figure 12.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 13.1 Key Drivers of Ready-to-Use Platform
Figure 14.1 Concluding Remarks: Current Biologic Fill / Finish Service Providers Market Landscape
Figure 14.2 Concluding Remarks: Current Small Molecule Fill / Finish Service Providers Market Landscape
Figure 14.3 Concluding Remarks: Partnerships and Collaborations
Figure 14.4 Concluding Remarks: Market Sizing and Opportunity Analysis

Aseptic Fill Finish Manufacturing Market by Type of Molecule, Type of Packaging Container Offered, Type of Drug Product, Scale of Operation, Company Size, Target Therapeutic Area and Geographical Regions : Industry Trends and Global Forecasts, Till 2035

Description

Table of Contents

List of Tables

ASEPTIC FILL FINISH MANUFACTURING MARKET: OVERVIEW

ASEPTIC FILL FINISH MANUFACTURING MARKET: GROWTH AND TRENDS

ASEPTIC FILL FINISH MANUFACTURING MARKET: KEY INSIGHTS

ASEPTIC FILL FINISH MANUFACTURING MARKET: KEY SEGMENTS

Example Players in the Aseptic Fill Finish Manufacturing Market

Primary Research Overview

ASEPTIC FILL FINISH MANUFACTURING MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. ASEPTIC FILL / FINISH SERVICE PROVIDERS LANDSCAPE

5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE

6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE

7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA

8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE

9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC

10. PARTNERSHIPS AND COLLABORATIONS

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING

13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

List of Figures